Signet Financial Management, LLC Jazz Pharmaceuticals PLC Transaction History

Signet Financial Management, LLC

$778 Million
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	BUY	$115.19 - $132.77 $396,253 - $456,728	3,440 Added 34.61%	13,380 $1.61 Million
Q4 2023 Jan 30, 2024	SELL	$114.26 - $136.0 $402,309 - $478,856	-3,521 Reduced 26.16%	9,940 $1.22 Million
Q3 2023 Oct 25, 2023	SELL	$122.0 - $145.31 $18,300 - $21,796	-150 Reduced 1.1%	13,461 $1.74 Million
Q2 2023 Jul 18, 2023	BUY	$122.5 - $147.16 $6,615 - $7,946	54 Added 0.4%	13,611 $1.69 Million
Q1 2023 Apr 17, 2023	BUY	$133.98 - $160.47 $89,230 - $106,873	666 Added 5.17%	13,557 $1.98 Million
Q4 2022 Feb 14, 2023	SELL	$129.72 - $159.85 $63,951 - $78,806	-493 Reduced 3.68%	12,891 $2.05 Million
Q3 2022 Nov 14, 2022	SELL	$126.59 - $161.18 $33,166 - $42,229	-262 Reduced 1.92%	13,384 $1.78 Million
Q2 2022 Aug 15, 2022	BUY	$141.59 - $168.66 $18,973 - $22,600	134 Added 0.99%	13,646 $2.13 Million
Q1 2022 May 13, 2022	BUY	$129.64 - $160.7 $407,458 - $505,080	3,143 Added 30.31%	13,512 $2.1 Million
Q4 2021 Feb 11, 2022	SELL	$119.87 - $145.67 $354,815 - $431,183	-2,960 Reduced 22.21%	10,369 $1.32 Million
Q3 2021 Nov 15, 2021	SELL	$128.64 - $184.79 $4,502 - $6,467	-35 Reduced 0.26%	13,329 $1.74 Million
Q2 2021 Aug 09, 2021	BUY	$160.2 - $186.42 $4,485 - $5,219	28 Added 0.21%	13,364 $2.37 Million
Q1 2021 May 05, 2021	BUY	$150.19 - $173.5 $72,391 - $83,627	482 Added 3.75%	13,336 $2.19 Million
Q4 2020 Feb 10, 2021	SELL	$140.71 - $165.05 $103,703 - $121,641	-737 Reduced 5.42%	12,854 $2.12 Million
Q3 2020 Nov 05, 2020	SELL	$105.46 - $144.13 $64,436 - $88,063	-611 Reduced 4.3%	13,591 $2.14 Million
Q2 2020 Aug 18, 2020	SELL	$95.68 - $121.88 $211,644 - $269,598	-2,212 Reduced 13.48%	14,202 $1.79 Million
Q1 2020 May 20, 2020	SELL	$87.74 - $152.74 $70,630 - $122,955	-805 Reduced 4.68%	16,414 $1.87 Million
Q4 2019 Jan 23, 2020	SELL	$117.65 - $153.73 $230,476 - $301,157	-1,959 Reduced 10.21%	17,219 $2.57 Million
Q3 2019 Nov 14, 2019	SELL	$125.18 - $143.24 $157,726 - $180,482	-1,260 Reduced 6.16%	19,178 $2.51 Million
Q2 2019 Aug 13, 2019	SELL	$125.55 - $144.48 $369,368 - $425,060	-2,942 Reduced 12.58%	20,438 $2.82 Million
Q1 2019 May 15, 2019	BUY	$121.81 - $142.95 $108,532 - $127,368	891 Added 3.96%	23,380 $3.03 Million
Q4 2018 Feb 14, 2019	SELL	$115.94 - $166.74 $558,714 - $803,520	-4,819 Reduced 17.65%	22,489 $2.79 Million
Q3 2018 Nov 14, 2018	SELL	$161.01 - $180.57 $254,878 - $285,842	-1,583 Reduced 5.48%	27,308 $4.59 Million
Q2 2018 Aug 10, 2018	BUY	$146.33 - $183.18 $4.22 Million - $5.28 Million	28,841 Added 57682.0%	28,891 $4.98 Million
Q1 2018 May 15, 2018	BUY	$135.59 - $157.16 $6,779 - $7,858	50 New	50 $8,000

Others Institutions Holding JAZZ

# of Institutions

512

Shares Held

57.5M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signet Financial Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signet Financial Management, LLC with notifications on news.

Account